Jul 21, 2026 08:32AM
Jul 21, 2026 08:30AM
May 18, 2026 04:01PM
May 11, 2026 07:01AM
May 11, 2026 07:00AM
May 8, 2026 09:00AM
May 8, 2026 09:00AM Alpha Tau Completes Patient Enrollment in its U.S. Pivotal Skin Cancer Study, Advancing Towards Goal of FDA Approval of Alpha DaRT® to Treat Recurrent Cutaneous Squamous Cell Carcinoma
Apr 23, 2026 09:02AM
Apr 23, 2026 09:02AM
Mar 9, 2026 04:02PM
Nov 20, 2025 04:05PM
Aug 11, 2025 04:02PM
May 19, 2025 04:01PM
Mar 12, 2025 04:02PM Alpha Tau Announces Full Year 2024 Financial Results and Provides Corporate Update
Jan 27, 2025 09:00AM
Nov 19, 2024 04:00PM
Oct 21, 2024 08:32AM
Oct 21, 2024 08:30AM
Mar 7, 2024 04:01PM
Nov 16, 2023 04:30PM
Mar 8, 2023 05:00PM Alpha Tau Announces Alpha DaRT™ Treatment of First Two Patients in its Pivotal Multicenter Recurrent Skin Cancer (ReSTART) Trial
Sep 8, 2022 04:05PM
Aug 25, 2022 04:05PM
Jun 8, 2022 09:10AM
Jun 8, 2022 09:10AM
Mar 28, 2022 08:00AM

326,122 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All